Lifeboat Foundation

IBM Research AI team demonstrated deep neural network (DNN) training with large arrays of analog memory devices at the same accuracy as a Graphical Processing Unit (GPU)-based system. This is a major step on the path to the kind of hardware accelerators necessary for the next AI breakthroughs. Why? Because delivering the Future of AI will require vastly expanding the scale of AI calculations.

Above – Crossbar arrays of non-volatile memories can accelerate the training of fully connected neural networks by performing computation at the location of the data.

This new approach allows deep neural networks to run hundreds of times faster than with GPUs, using hundreds of times less energy.

Continue reading “IBM overcomes von Neumann bottleneck for AI hundreds of time faster using hundreds of times less energy” »

Water-scarce cities could get a new source of the precious resource through a simple and cost-effective technology.

What did they find out?

NASA’s Curiosity rover has uncovered the best evidence yet that life may have once existed on Mars.

Continue reading “Breakthrough in search for Martian life as Curiosity finds organic matter and seasonal methane” »

A breakthrough stem cell treatment that promises the first effective cure for heart disease will be offered to British patients this year, The Sunday Telegraph can reveal.

Hundreds of thousands stand to benefit after regulators approved a major trial of the regenerative drug capable of shrinking fatal scar tissue which follows a heart attack.

The “off-the-shelf” therapy, which can be harvested for thousands of recipients from one healthy donor, will begin being administered to patients at London’s Royal Brompton Hospital in November.

Continue reading “Heart disease stem cell therapy can shrink deadly scar tissue” »

http://www.thepathmag.com/can-you-actually-hack-your-dna-to-slow-down-aging/

Many technologies / interventions progressing down the development pathways in the coming years — but there are a lot of free, common sense adjustments you can make today:

M en with previously “untreatable” prostate cancer are being kept alive by a new drug in what experts believe may be a breakthrough for patients with the worst form of the disease.

A British trial has for the first time shown that state-of-the art immunotherapy can be used to target prostate tumours.

The study at the Royal Marsden Hospital in London found more than a third of men who had run out of existing options were still alive and one in ten had not seen their tumours grow after a year of taking Pembrolizumab, which targets a gateway helps the immune system to attack cancer cells.

Next week’s proposals are unlikely to contain major surprises, because the commission has unveiled its main ideas over the past months, in particular its overall 7-year budget plan, issued on 2 May. Although Horizon Europe will keep Horizon 2020’s main features, the commission has laid the groundwork for several novelties, including a new agency to tackle the continent’s perennial innovation problem and a big, separate push on collaborative defense research. But contentious negotiations lie ahead. The United Kingdom is negotiating the terms of its impending exit from the European Union, and some member states want to tighten budgets. Meanwhile, research advocates want more generous spending, noting the low application success rates in Horizon 2020—a frustrating 11.9% so far.

Commission seeks €97.6 billion for “Horizon Europe”.

A new wonderful breakthrough of our time.

Scientists raise ethical concerns as the brain cells of decapitated pigs are kept alive for 36 hours.